Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximeng Lin

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Gut|February 11, 2016
Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesisYingcheng Yang, Ximeng Lin, Xinyuan Lu, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in miceGuojun Hou, Lei Chen, Gang Liu, et al.
Cancer Letters|February 7, 2016
Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinomaLiang Li, Jianguo Chen, Xin Chen, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Gut|February 11, 2016
Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesisYingcheng Yang, Ximeng Lin, Xinyuan Lu, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in miceGuojun Hou, Lei Chen, Gang Liu, et al.
Cancer Letters|February 7, 2016
Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinomaLiang Li, Jianguo Chen, Xin Chen, et al.
Pageof 3